African-Caribbean Cancer Consortium Scientific and Training Conference

Information

  • Research Project
  • 8319100
  • ApplicationId
    8319100
  • Core Project Number
    R13MD007156
  • Full Project Number
    9R13MD007156-02A1
  • Serial Number
    007156
  • FOA Number
    PA-10-071
  • Sub Project Id
  • Project Start Date
    6/21/2012 - 12 years ago
  • Project End Date
    3/31/2013 - 11 years ago
  • Program Officer Name
    WILLIAMS, KESI
  • Budget Start Date
    6/21/2012 - 12 years ago
  • Budget End Date
    3/31/2013 - 11 years ago
  • Fiscal Year
    2012
  • Support Year
    02
  • Suffix
    A1
  • Award Notice Date
    6/21/2012 - 12 years ago

African-Caribbean Cancer Consortium Scientific and Training Conference

DESCRIPTION (provided by applicant): The African-Caribbean Cancer Consortium (AC3) was conceived in 2006 for the study of viral, genetic and environmental risk factors in populations of African descent. The establishment of this Consortium has provided new collaborative opportunities for cancer research among investigators throughout the various islands in the Caribbean, United States and Africa. Since the establishment of the AC3, 71 investigators have joined and are conducting collaborative studies of cancer risk in the US, Caribbean islands and Africa. Cervical and prostate cancer studies are ongoing in Brooklyn, USA, the Bahamas, Jamaica, Trinidad and Tobago, Guyana as well as Nigeria. Head and neck cancer studies are ongoing in the US (Pittsburgh and Brooklyn). Breast cancer studies are ongoing in Brooklyn, Trinidad and Tobago, Barbados and Guyana. The studied populations include African-Americans, African-Caribbean, African as well as immigrant African-descent populations living in the United States. We seek funding to support our next conference entitled: Continuing to Build Capacity to Address Health Disparities in Populations of African Ancestry: a Focus on Women's Cancers. The purpose of this conference is to provide the forum/infrastructure through which AC3 participating investigators and non-members will be able to 1) present cancer research data and progress reports of newly funded studies or evaluate new research ideas for studies that focus on gene- environment interactions and cancer disparities in populations of African descent; 2) describe the health resources, screening and other preventive activities present or absent that may attribute to higher cancer incidence and mortality in their study populations; 3) to formally discuss the coordination of current and future research collaborations; 4) provide a forum for training junior investigators and students who are interested in pursuing careers in health disparities research 5) raise the awareness throughout the local Philadelphia community about the importance of minority participation research and clinical trials; and 6) to seek funding from the NIMHD and NCI to support case-control studies of cancer risk across these at-risk populations. This upcoming meeting will focus our attention to address a significant need for studies related to cancer in women of African descent and will promote studies that will fill in the gaps in the existing knowledge about cancer risk and outcomes related to women's cancers in African-descent populations. The conference will also provide a forum for training and career development that will lead to an increase in diversity among young cancer research investigators. The uniqueness of this conference is that it serves not only as a forum for training, research presentation and interaction, but also promotes the development and coordination of research studies that involve African-American, African-Caribbean and African populations as a whole.

IC Name
National Institute on Minority Health and Health Disparities
  • Activity
    R13
  • Administering IC
    MD
  • Application Type
    9
  • Direct Cost Amount
    50000
  • Indirect Cost Amount
  • Total Cost
    50000
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    375
  • Ed Inst. Type
  • Funding ICs
    NIMHD:50000\
  • Funding Mechanism
    OTHER RESEARCH-RELATED
  • Study Section
    ZMD1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    FOX CHASE CANCER CENTER
  • Organization Department
  • Organization DUNS
    073724262
  • Organization City
    PHILADELPHIA
  • Organization State
    PA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    191112434
  • Organization District
    UNITED STATES